Otsuka Holdings Co., Ltd. (FRA:OS1)

Market Cap	26.11B
Revenue (ttm)	13.93B
Net Income (ttm)	2.59B
Shares Out	n/a
EPS (ttm)	4.86
PE Ratio	10.09
Forward PE	n/a
Dividend	0.79 (1.59%)
Ex-Dividend Date	Dec 29, 2025

Volume	n/a
Average Volume	n/a
Open	50.50
Previous Close	50.50
Day's Range	50.50 - 50.50
52-Week Range	37.60 - 51.50
Beta	n/a
RSI	56.89
Earnings Date	Feb 13, 2026

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipme...

• Industry: Pharmaceutical Preparations
• Founded: 1921
• Employees: 35,338
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OS1

Financial Performance

In 2024, Otsuka Holdings's revenue was 2.33 trillion, an increase of 15.42% compared to the previous year's 2.02 trillion. Earnings were 343.12 billion, an increase of 182.13%.

Financial numbers in JPY